The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
The requested protein is correctly identified as Swi4, encoded by SWI4/YER111C in Saccharomyces cerevisiae strain S288c and represented by UniProt P25302. Organism-specific literature identifies Swi4 as the sequence-specific DNA-binding subunit of SBF—the Swi4/Swi6 cell-cycle transcription factor—and not as an enzyme, transporter, or structural cell-wall protein. No evidence from similarly named proteins in other organisms was used to annotate this target. The supplied ankyrin-repeat, APSES/KilA-like helix-turn-helix, and SWI6-like annotations agree with experimentally mapped Swi4 regions. (baetz1999regulationofcell pages 1-2, su2024controlofmeiotic pages 2-4, siegmund1996thesaccharomycescerevisiae pages 1-2)
Swi4’s primary function is to recognize SCB promoter elements, with the canonical consensus 5′-CACGAAA-3′, and recruit/regulate transcriptional machinery with Swi6. SBF activates a late-G1 transcriptional program that couples commitment at Start to G1-cyclin production, bud emergence, cell-wall synthesis, and other events required for a new division cycle. Swi4 acts primarily in the nucleus, where its activity is controlled by Swi6, Whi5, G1 and mitotic cyclin–Cdk1 complexes, promoter occupancy, and cell-state-specific regulation. (baetz1999regulationofcell pages 1-2, siegmund1996thesaccharomycescerevisiae pages 1-2, nishikawa2008asystematiccell pages 126-133)
The literature specifically identifies budding-yeast SWI4/YER111C as the gene encoding the Swi4 component of SBF; SBF contains Swi4 plus Swi6, whereas the related MBF complex substitutes Mbp1 for Swi4 while retaining Swi6. This establishes that the target is the S288c budding-yeast protein described in the query rather than a similarly named protein from another fungus. (su2024controlofmeiotic pages 2-4)
The alternative name ART1 should not be confused with unrelated proteins carrying ART-family terminology. For functional annotation, SWI4/YER111C/P25302 is the unambiguous identifier set.
Swi4 is the DNA-recognition and promoter-targeting subunit of SBF. SBF binds repeated SCB elements in promoters and activates transcription around the G1/S transition. The best-supported SCB consensus is CACGAAA. Swi6 is principally regulatory: it interacts with Swi4, relieves Swi4 autoinhibition, and participates in cell-cycle-dependent control of transcription. Thus, the closest substrate-specificity analogy is recognition of SCB-containing double-stranded promoter DNA—not catalysis of a chemical reaction. (baetz1999regulationofcell pages 1-2, siegmund1996thesaccharomycescerevisiae pages 1-2)
Canonical experimentally supported SBF-responsive genes include CLN1, CLN2, PCL1, PCL2, HO, and multiple genes required for budding or cell-wall biosynthesis. CLN1 and CLN2 encode G1 cyclins, creating positive feedback in which SBF-dependent cyclin expression further increases G1-Cdk1 activity and reinforces Start. HO links SBF regulation to mating-type switching, while morphogenesis and wall-biosynthesis targets coordinate physical bud formation with cell-cycle commitment. (baetz1999regulationofcell pages 1-2, siegmund1996thesaccharomycescerevisiae pages 1-2)
Experimental dissection supports three principal functional regions:
Full-length Swi4 is poorly competent for SCB binding without Swi6 because its C terminus masks the N-terminal DNA-binding region. Mutations in or removal of the extreme C terminus restore DNA binding or transcriptional activity, and direct interaction between C- and N-terminal fragments supports a physical autoinhibitory mechanism. Evidence that full-length Swi4 is monomeric favors intramolecular masking rather than inhibition through Swi4 oligomerization. Swi6 binding is therefore not merely complex assembly: it changes Swi4 into a DNA-binding-competent regulatory state. (baetz1999regulationofcell pages 1-2)
The supplied domain list is consequently coherent with the literature: the APSES/KilA-like region explains DNA recognition, ankyrin repeats provide interaction surfaces, and the SWI6-like/conserved C-terminal region supports regulated partner binding.
Swi4 is predominantly nuclear and was reported to remain nuclear throughout the mitotic cell cycle. Its activity is therefore not regulated mainly by complete Swi4 nuclear export. Instead, regulation occurs through its autoinhibited versus Swi6-bound state, recruitment of Whi5, cyclin–Cdk1-dependent phosphorylation, changing promoter occupancy, and the cell-cycle-dependent localization of Swi6. Swi6 is enriched in the nucleus during late mitosis/G1 but becomes more cytoplasmic during S, G2, and early mitosis. (baetz1999regulationofcell pages 1-2)
The physiologically relevant site of Swi4 action is consequently chromatin in the nucleus, especially SCB-containing promoters. There is no credible evidence that Swi4 is secreted, membrane-associated, or a structural constituent of the cell wall.
Before Start, SBF can occupy promoters in a transcriptionally restrained complex containing Whi5. Whi5 recruitment to CLN2 and PCL1 promoters depends on SWI4, supporting direct repression through promoter-bound SBF. Following release from G1 arrest, Whi5 disappeared from the PCL1 promoter within approximately 30 minutes, while Swi6 remained transiently associated. Deleting WHI5 advances G1/S transcription to a smaller mean cell size but does not abolish its periodicity; Whi5 therefore controls onset more strongly than the basic oscillator. (nishikawa2008asystematiccell pages 126-133)
As cells grow, G1 cyclin–Cdk1 activity rises. Cln3/Cdk1 and downstream Cln1/2-Cdk1-associated events relieve repression, permitting SBF to activate CLN1/2 and the broader budding/morphogenesis program. Older models emphasized direct Whi5 phosphorylation; current synthesis recognizes that phosphorylation of Whi5 or Swi6 can provide partially redundant routes to timely SBF activation. A double non-phosphorylatable WHI5-12A SWI6-SA4 mutant was reported to be approximately 40% larger, indicating substantial functional overlap rather than a single obligatory phosphorylation switch. (ravi2024modelingthestart pages 5-6)
SBF must be turned off after its G1 pulse. Mitotic Clb–Cdc28/Cdk1 complexes repress SBF, and the Swi4 ankyrin repeats physically associate with Clb2–Cdc28 in vivo. Later cyclin-dependent regulation promotes loss of SBF from promoters during G2/M, helping ensure that G1 cyclins are activated once rather than repeatedly in the same cycle. (siegmund1996thesaccharomycescerevisiae pages 1-2, ravi2024modelingthestart pages 26-28)
This architecture separates two regulatory operations: G1 cyclin–Cdk1 activates a previously restrained promoter complex, while mitotic cyclin–Cdk1 contributes to promoter dissociation and termination of the transcriptional pulse.
Swi4’s central biological role is to coordinate Start-associated transcription with the cellular structures needed for division. SBF targets include G1 cyclins and genes involved in budding and cell-wall biosynthesis. Swi4 therefore regulates wall construction indirectly through transcription; it is not itself a wall enzyme or scaffold. (baetz1999regulationofcell pages 1-2)
SBF regulation of HO, together with cell-cycle-dependent control at relevant loci, links Swi4 to the timing of mating-type switching. This is a specialized extension of its nuclear transcription-factor function rather than a separate catalytic activity. (baetz1999regulationofcell pages 1-2, siegmund1996thesaccharomycescerevisiae pages 1-2)
Recent work shows that Swi4 must be actively suppressed when cells enter meiosis. Swi4 abundance declined by approximately 30% after two hours of meiotic induction, whereas Mbp1 and Swi6 increased. A long undecoded transcript isoform, SWI4 LUTI, represses the downstream canonical SWI4 promoter and reduces translation through upstream open reading frames; this mechanism cooperates with Whi5 to restrict SBF. (su2024controlofmeiotic pages 2-4)
Forced SWI4 expression prematurely activated SBF targets—including CLN1, CLN2, and PCL1—reduced early meiotic gene expression, and delayed meiotic entry. Deleting CLN1 or CLN2 partially rescued that delay. The mechanistic interpretation is that excess G1 cyclins disrupt interaction of the meiotic regulator Ime1 with Ume6, thereby antagonizing the meiotic program. Reported statistical effects included CLN1 p=0.0351, CLN2 p=0.0013, and altered meiotic progression with Mann–Whitney p=0.0045. (su2024controlofmeiotic pages 16-18, su2024controlofmeiotic pages 2-4)
Su, Yendluri, and Ünal’s work, available in its cited February 2024 version, extends Swi4 biology beyond the canonical mitotic Start switch. It establishes that transcriptional interference/translation control through SWI4 LUTI and protein-level repression through Whi5 jointly prevent inappropriate activation of the mitotic SBF program during meiotic entry. This is direct experimental evidence that Swi4 abundance itself is a regulated determinant of cell-state choice. Publication: Control of meiotic entry by dual inhibition of a key mitotic transcription factor, DOI: https://doi.org/10.7554/eLife.90425.2. (su2024controlofmeiotic pages 16-18, su2024controlofmeiotic pages 2-4)
Ravi, Samart, and Zwolak published START-BYCC in PLOS Computational Biology on August 2, 2024. The model explicitly represents Swi4/SBF, Swi6, Whi5, Mbp1/MBF, cyclin-dependent phosphorylation, promoter binding, and nuclear–cytoplasmic transport. It expanded the Start subsystem from one species and eight parameters in an earlier model to 51 species and 56 parameters. (ravi2024modelingthestart pages 25-26, ravi2024modelingthestart pages 6-9)
The authors simulated more than 200 mutants, including over 100 Start mutants, and reported successful fitting of approximately 95% of mutant phenotypes. The model reproduced viability, cell-size, Start-timing, and rescue relationships; examples included rescue of cln3Δ swi4Δ by whi5Δ, sic1Δ, or GAL-BCK2, and rescue of swi4Δ swi6Δ by GAL-CLB5 or GAL-CLN2 but not GAL-CLN3. Publication: Modeling the START transition in the budding yeast cell cycle, DOI: https://doi.org/10.1371/journal.pcbi.1012048. (ravi2024modelingthestart pages 23-25, ravi2024modelingthestart pages 9-10)
These results are valuable as quantitative integration, but they are not independent biochemical proof for every modeled interaction. Assumptions include compartment-volume ratios, Hill-function approximations for multisite phosphorylation, inferred stoichiometries, and lumped cyclin species. The model should therefore guide perturbation design and consistency checking rather than replace direct promoter-occupancy, biochemical, or live-cell experiments. (ravi2024modelingthestart pages 26-28, ravi2024modelingthestart pages 25-26)
The following table distinguishes direct experimental findings from computational synthesis.
| Feature/question | Best-supported annotation | Evidence type | Key source with year and DOI/URL |
|---|---|---|---|
| Identity | SWI4/YER111C encodes Swi4, the S. cerevisiae SBF-specific DNA-binding subunit; this matches UniProt P25302 and is distinct from similarly named proteins in other fungi. | Curated identity plus organism-specific experimental literature | Su et al. (2024), eLife 90425.2 (su2024controlofmeiotic pages 2-4) |
| Primary molecular function / SBF | Swi4 forms SBF (SCB-binding factor) with the regulatory subunit Swi6. Swi4 supplies sequence-specific promoter recognition; Swi6 relieves Swi4 autoinhibition and supports regulated transcription. It is a transcription factor, not an enzyme or transporter. | Direct DNA-binding, protein-interaction, and mutational experiments | Baetz & Andrews (1999), 10.1128/MCB.19.10.6729 (baetz1999regulationofcell pages 1-2) |
| DNA motif / substrate specificity | SBF recognizes repeated SCB elements, consensus 5′-CACGAAA-3′, in target promoters. The molecular substrate is promoter DNA rather than a small molecule. | Direct biochemical DNA-binding and promoter-footprinting evidence | Siegmund & Nasmyth (1996), 10.1128/MCB.16.6.2647 (siegmund1996thesaccharomycescerevisiae pages 1-2) |
| Domains and architecture | The N-terminal region contains the APSES/KilA-like DNA-binding domain; the first 197 residues are sufficient for DNA binding. A central region contains four ankyrin repeats, which associate with Clb2–Cdc28, while the conserved C terminus binds Swi6 and intramolecularly masks the DNA-binding region. This agrees with the supplied InterPro APSES, ankyrin-repeat, and SWI6-like annotations. | Domain deletions, point mutants, binding assays, monomer-state analysis, and co-immunoprecipitation | Baetz & Andrews (1999), 10.1128/MCB.19.10.6729; Siegmund & Nasmyth (1996), 10.1128/MCB.16.6.2647 (baetz1999regulationofcell pages 1-2, siegmund1996thesaccharomycescerevisiae pages 1-2) |
| Cellular localization | Swi4 is principally nuclear and remains nuclear throughout the mitotic cell cycle. Regulation depends substantially on promoter occupancy, Swi6 localization, and inhibitory/activating partners rather than wholesale Swi4 nuclear export. | Direct protein-localization experiments | Baetz & Andrews (1999), 10.1128/MCB.19.10.6729 (baetz1999regulationofcell pages 1-2) |
| Canonical targets and processes | Well-supported targets include CLN1, CLN2, PCL1, PCL2, HO, and genes involved in budding and cell-wall biosynthesis. Accordingly, Swi4 coordinates G1/S cyclin production, bud emergence, morphogenesis, mating-type switching, and Start-associated transcription. | Promoter analysis, genetics, expression assays, and DNA occupancy | Baetz & Andrews (1999), 10.1128/MCB.19.10.6729; Siegmund & Nasmyth (1996), 10.1128/MCB.16.6.2647 (baetz1999regulationofcell pages 1-2, siegmund1996thesaccharomycescerevisiae pages 1-2) |
| Start activation | Before Start, promoter-bound SBF is restrained by Whi5. Rising G1 cyclin–Cdk1 activity promotes release/inactivation of repression and SBF-dependent positive feedback through CLN1/2. Whi5 occupancy at CLN2/PCL1 is Swi4-dependent and disappears from PCL1 within approximately 30 min after release from G1 arrest. | Direct ChIP/promoter-occupancy, genetics, and cell-cycle experiments | Nishikawa (2008), summarized evidence on Swi4-dependent Whi5 recruitment (nishikawa2008asystematiccell pages 126-133); Ravi et al. (2024), 10.1371/journal.pcbi.1012048 (ravi2024modelingthestart pages 5-6) |
| G2 shutoff | Mitotic Clb–Cdc28 activity represses SBF: Swi4 ankyrin repeats bind Clb2–Cdc28, and phosphorylation-associated regulation promotes loss of SBF from promoters in G2/M, preventing repeated G1 transcription within one cycle. | Direct co-immunoprecipitation and cell-cycle promoter-occupancy evidence; later computational integration | Siegmund & Nasmyth (1996), 10.1128/MCB.16.6.2647; Ravi et al. (2024), 10.1371/journal.pcbi.1012048 (siegmund1996thesaccharomycescerevisiae pages 1-2, ravi2024modelingthestart pages 26-28) |
| Cell-wall role | SBF directly links cell-cycle entry to expression of cell-wall biosynthetic and budding genes. This is a transcriptional coordination role rather than a structural cell-wall function; stress-responsive signaling can additionally act through the Swi4/Swi6 system. | Direct target-gene and genetic evidence; pathway interpretation | Baetz & Andrews (1999), 10.1128/MCB.19.10.6729 (baetz1999regulationofcell pages 1-2) |
| 2024 meiosis development | During meiotic entry, Swi4 abundance falls by approximately 30% after 2 h. A SWI4 LUTI transcript and Whi5 jointly suppress SBF; inappropriate SWI4 expression activates CLN1/CLN2/PCL1, reduces early-meiotic transcription, and delays meiosis. Reported effects included CLN1 p=0.0351, CLN2 p=0.0013, and meiotic progression p=0.0045. | Direct time-course, expression, genetic, and meiotic-progression experiments | Su et al. (2024 version), 10.7554/eLife.90425.2 (su2024controlofmeiotic pages 16-18, su2024controlofmeiotic pages 2-4) |
| 2024 START-BYCC model | START-BYCC explicitly represents Swi4/SBF, Swi6, Whi5, phosphorylation, promoter binding, and nuclear–cytoplasmic transport. It expanded the START module from 1 species/8 parameters to 51 species/56 parameters, simulated more than 200 mutants including over 100 START mutants, and reported approximately 95% successful phenotype fitting. These values reflect computational synthesis and validation against published phenotypes—not new direct biochemical measurements of Swi4. | Computational mechanistic synthesis using nonlinear ODEs, mutant-phenotype fitting, and independent numerical checks | Ravi, Samart & Zwolak (published August 2, 2024), 10.1371/journal.pcbi.1012048 (ravi2024modelingthestart pages 9-10, ravi2024modelingthestart pages 6-9) |
Table: Compact evidence map for the verified S. cerevisiae Swi4 protein P25302/YER111C, separating direct experimental findings from the 2024 START-BYCC computational synthesis.
Swi4 is primarily a research-system regulator, not a clinical target with an approved therapeutic application. Its established applications include:
The strongest functional annotation is: nuclear, sequence-specific DNA-binding transcription factor; SBF-specific subunit controlling the G1/S transcriptional program. This conclusion is supported by direct DNA-binding studies, domain mutations, protein-interaction assays, promoter occupancy, localization, and classical genetics. The autoinhibition/Swi6-release mechanism and SCB specificity are especially well supported. (baetz1999regulationofcell pages 1-2, siegmund1996thesaccharomycescerevisiae pages 1-2)
Several qualifications are important:
SWI4/YER111C encodes the nuclear transcription factor Swi4, UniProt P25302. Through its N-terminal APSES-like DNA-binding domain, Swi4 recognizes SCB promoter elements; its ankyrin repeats and conserved C terminus integrate interactions with cyclin–Cdk1 complexes and Swi6. In SBF, it activates G1 cyclins, budding, and cell-wall-biogenesis genes at Start. Whi5 restrains promoter-bound SBF before commitment, G1 cyclin–Cdk1 activity promotes activation, and mitotic Clb–Cdk1 activity contributes to shutoff. Recent research has broadened this canonical annotation by showing that SWI4 expression is actively repressed during meiotic entry and by incorporating Swi4 regulation into a quantitatively validated whole-Start model. (baetz1999regulationofcell pages 1-2, su2024controlofmeiotic pages 16-18, siegmund1996thesaccharomycescerevisiae pages 1-2, ravi2024modelingthestart pages 9-10)
References
(baetz1999regulationofcell pages 1-2): Kristin Baetz and Brenda Andrews. Regulation of cell cycle transcription factor swi4 through auto-inhibition of dna binding. Molecular and Cellular Biology, 19:6729-6741, Oct 1999. URL: https://doi.org/10.1128/mcb.19.10.6729, doi:10.1128/mcb.19.10.6729. This article has 63 citations and is from a domain leading peer-reviewed journal.
(su2024controlofmeiotic pages 2-4): Amanda J. Su, Siri C. Yendluri, and Elçin Ünal. Control of meiotic entry by dual inhibition of a key mitotic transcription factor. ArXiv, Feb 2024. URL: https://doi.org/10.7554/elife.90425.2, doi:10.7554/elife.90425.2. This article has 11 citations.
(siegmund1996thesaccharomycescerevisiae pages 1-2): Robert F. Siegmund and Kim A. Nasmyth. The saccharomyces cerevisiae start-specific transcription factor swi4 interacts through the ankyrin repeats with the mitotic clb2/cdc28 kinase and through its conserved carboxy terminus with swi6. Molecular and Cellular Biology, 16:2647-2655, Jun 1996. URL: https://doi.org/10.1128/mcb.16.6.2647, doi:10.1128/mcb.16.6.2647. This article has 108 citations and is from a domain leading peer-reviewed journal.
(nishikawa2008asystematiccell pages 126-133): JL Nishikawa. A systematic cell size screen in saccharomyces cerevisiae and characterization of the start inhibitor whi5. Unknown journal, 2008.
(ravi2024modelingthestart pages 5-6): Janani Ravi, Kewalin Samart, and Jason Zwolak. Modeling the start transition in the budding yeast cell cycle. Aug 2024. URL: https://doi.org/10.1371/journal.pcbi.1012048, doi:10.1371/journal.pcbi.1012048. This article has 1 citations and is from a highest quality peer-reviewed journal.
(ravi2024modelingthestart pages 26-28): Janani Ravi, Kewalin Samart, and Jason Zwolak. Modeling the start transition in the budding yeast cell cycle. Aug 2024. URL: https://doi.org/10.1371/journal.pcbi.1012048, doi:10.1371/journal.pcbi.1012048. This article has 1 citations and is from a highest quality peer-reviewed journal.
(su2024controlofmeiotic pages 16-18): Amanda J. Su, Siri C. Yendluri, and Elçin Ünal. Control of meiotic entry by dual inhibition of a key mitotic transcription factor. ArXiv, Feb 2024. URL: https://doi.org/10.7554/elife.90425.2, doi:10.7554/elife.90425.2. This article has 11 citations.
(ravi2024modelingthestart pages 25-26): Janani Ravi, Kewalin Samart, and Jason Zwolak. Modeling the start transition in the budding yeast cell cycle. Aug 2024. URL: https://doi.org/10.1371/journal.pcbi.1012048, doi:10.1371/journal.pcbi.1012048. This article has 1 citations and is from a highest quality peer-reviewed journal.
(ravi2024modelingthestart pages 6-9): Janani Ravi, Kewalin Samart, and Jason Zwolak. Modeling the start transition in the budding yeast cell cycle. Aug 2024. URL: https://doi.org/10.1371/journal.pcbi.1012048, doi:10.1371/journal.pcbi.1012048. This article has 1 citations and is from a highest quality peer-reviewed journal.
(ravi2024modelingthestart pages 23-25): Janani Ravi, Kewalin Samart, and Jason Zwolak. Modeling the start transition in the budding yeast cell cycle. Aug 2024. URL: https://doi.org/10.1371/journal.pcbi.1012048, doi:10.1371/journal.pcbi.1012048. This article has 1 citations and is from a highest quality peer-reviewed journal.
(ravi2024modelingthestart pages 9-10): Janani Ravi, Kewalin Samart, and Jason Zwolak. Modeling the start transition in the budding yeast cell cycle. Aug 2024. URL: https://doi.org/10.1371/journal.pcbi.1012048, doi:10.1371/journal.pcbi.1012048. This article has 1 citations and is from a highest quality peer-reviewed journal.